Table 3.
Treatment Effect | |||||
---|---|---|---|---|---|
Control Group a |
Intervention Group a | Adj. OR (95% CI) b |
Adj. Mean Difference (95% CI) b |
Adj. p-Value |
|
Pregnancy and birth outcomes | |||||
Gestational diabetes mellitus | 11.3% | 12.4% | 1.12 (0.77 to 1.63) | 0.537 | |
Dietary treatment | 4.0% | 4.2% | 1.05 (0.55 to 2.02) | 0.876 | |
Insulin treatment | 2.2% (n = 15) | 1.9% (n = 15) | c | c | |
Bleeding | 5.1% | 2.6% | 0.5 (0.23 to 1.10) | 0.084 | |
Gestational hypertension | 2.4% (n = 16) | 1.7% (n = 13) | c | c | |
Preterm birth | 7.5% | 9.4% | 1.28 (0.69 to 2.36) | 0.428 | |
Caesarean section | 31.6% | 35.2% | 1.19 (0.86 to 1.64) | 0.301 | |
Instrumental delivery | 6.9% | 7.9% | 1.16 (0.68 to 1.96) | 0.592 | |
Neonatal outcomes | |||||
Birth weight, g | 3329.7 | 3332.1 | 2.47 (−57 to 61.94) | 0.935 | |
Birth length, cm | 51.5 | 51.4 | −0.14 (−0.64 to 0.35) | 0.572 | |
LGA | 5.9% | 4.6% | 0.76 (0.44 to 1.31) | 0.320 | |
SGA | 8.5% | 8.4% | 1 (0.58 to 1.73) | 0.993 | |
Macrosomia (birthweight > 4000 g) |
10.3% | 8.2% | 0.76 (0.51 to 1.13) | 0.172 | |
Abnormal 5 min Apgar-score (≤6) |
2.1% (n = 12) | 0.5% (n = 3) | c | c |
a Estimated shares/means; in cases of small number of cases, no model-based estimations could be obtained and raw shares are displayed in italics. b Adjusted for prepregnancy BMI, parity, age, migration status, and educational level. c No statistical modeling due to small number of cases.